ClinicalTrials.Veeva

Menu

Thromboembolic Events in Severe COVID-19 Patients (COVICLOT)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Pulmonary Thromboembolism

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed infection with the Sars-CoV-2 virus (RT-PCR)
  • Hospitalization in Intensive Care Unit
  • Age over 18 years Old

Exclusion criteria

  • Refusal of the patient to participate in data collection

Trial contacts and locations

1

Loading...

Central trial contact

Saïd CHAYER, PhD, HDR; Charles TACQUARD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems